Liquid Biopsies and Minimally-Invasive Diagnostics 2016
Time:September 29-30, 2016
Country&Region: United States
Venue:San Diego, California, USA
Organizer:SELECTB10
The 3rd Annual Liquid Biopsies and Minimally-Invasive Diagnostics 2016 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.
The Liquid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
The Minimally-Invasive Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
Call for Posters
You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 16 September 2016
Agenda Topics
- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNA and Circulating microRNA/Long Non-Coding RNA
- Extracellular Vesicles (EVs): Potential for Development of Liquid Biopsies
- US vs. EU vs. Asia/Pacific Regulatory Landscape for Novel Minimally-Invasive Diagnostics
|
Confirmed Speakers to date
Lyle Arnold, Chief Scientific Officer, Biocept
Iwijn De Vlaminck, Robert N. Noyce Assistant Professor in Life Science and Technology Meinig School of Biomedical Engineering, Cornell University
Dolores Di Vizio, Professor, Cedars Sinai Medical Center
Muller Fabbri, Assistant Professor, University of Southern California
Audrey Goddard, Vice President, Genomic Sciences, Genomic Health, Inc.
Louise Laurent, Associate Professor, University of California-San Diego
Ian Papautsky, Professor, University of Cincinnati
Kendall Van Keuren-Jensen, Associate Professor, Translational Genomics Research Institute
|
Pharma Sources Insight January 2025
